R

RPRX

RPRX

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
RPRX Live QuoteReal-time
$67.72
+$5.57(+8.96%)1M
Day Range$67.57 – $68.98
Open$68.42
Previous Close$68.67
Volume2.81M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$39.48B
P/E Ratio (TTM)44.9
Forward P/E34.0
EPS (TTM)$1.53
Price to Book4.5
Dividend Yield1.35%
Beta (Volatility)0.36
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $67.72 (93%)
Low: $36.68High: $70.13
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$73.50-51.0% upside

Insider Buys

0

$0

Insider Sales

3

$23.79M

Total Volume

$23.79M

37 transactions

Net Activity

$23.79M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
25CONFIDENCE

Sentiment Rating

Moderate Distribution

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
C
1

Coyne Terrance P.

EVP, CFO

0 buys1 sells

$17.69M total

H
2

Hite Christopher

EVP, COB, Partnering

0 buys1 sells

$5.85M total

U
3

Urist Marshall

EVP, Research, Investments

0 buys1 sells

$239K total

M
4

Multiple Insiders

S - Sale Insiders

0 buys34 sells

$0 total

Trading History
RPRX insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 16, 2026

4 days ago

Coyne Terrance P.

EVP, CFO

CFO
Sell257.1K$68.81$17.69M

Sep 28, 2026

1 months ago

Urist Marshall

EVP, Research, Investments

EVP
Sell4.1K$57.88$239K

Sep 22, 2026

1 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell293.6K$-100000.00$0

Sep 22, 2026

1 months ago

Hite Christopher

EVP, COB, Partnering

EVP
Sell100.0K$58.53$5.85M

Aug 18, 2026

3 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell393.6K$-100000.00$0

Aug 13, 2026

3 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell50.4K$-11002.00$0

Jun 30, 2026

4 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell499.4K$-130000.00$0

Jul 1, 2026

4 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell19.0K$-9099.00$0

Jun 23, 2026

5 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell629.4K$-150000.00$0

Jun 24, 2026

4 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell9.1K$-9098.00$0

May 26, 2026

5 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell50.4K$-64399.00$0

May 20, 2026

6 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell37.2K$-13684.00$0

May 14, 2026

6 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell50.9K$-13684.00$0

Apr 28, 2026

6 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell90.5K$-34791.00$0

Apr 1, 2026

7 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell125.3K$-34791.00$0

Mar 23, 2026

8 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell160.1K$-34791.00$0

Mar 2, 2026

8 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell194.9K$-34791.00$0

Feb 23, 2026

9 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell229.7K$-34791.00$0

Feb 2, 2026

9 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell237.9K$-243541.00$0

Jan 30, 2026

9 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell26.4K$-20000.00$0

Jan 23, 2026

10 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell46.4K$-20000.00$0

Jan 20, 2026

10 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell481.4K$-69582.00$0

Jan 16, 2026

10 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell66.4K$-20000.00$0

Jan 9, 2026

10 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell86.4K$-20000.00$0

Jan 2, 2026

10 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell551.0K$-69582.00$0

Dec 26, 2025

10 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell126.4K$-20000.00$0

Dec 19, 2025

11 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell146.4K$-20000.00$0

Dec 17, 2025

11 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell779.9K$-110000.00$0

Dec 16, 2025

11 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell166.4K$-20000.00$0

Dec 15, 2025

11 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell620.6K$-69582.00$0

Dec 5, 2025

11 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell186.4K$-41576.00$0

Dec 3, 2025

11 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell889.9K$-110000.00$0

Dec 1, 2025

11 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell690.1K$-69582.00$0

Nov 24, 2025

12 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell759.7K$-69582.00$0

Nov 19, 2025

12 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell999.9K$-135426.00$0

Nov 17, 2025

12 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell829.3K$-69594.00$0

Aug 11, 2025

15 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell194.8K$-33500.00$0
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
RPRX Buy Conviction0%
Industry Rank#96 of 570
Volume Contribution0.1%
Total Industry Activity$16.44B

RPRX has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. RPRX ranks #96 in insider activity out of 570 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for RPRX

Over the last 90 days, corporate insiders at RPRX (RPRX) engaged in a total of 37 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 3 were sales. The total volume of insider trading reached $23.79M.

The net insider activity for RPRX shows a net selling bias of $23.79M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Coyne Terrance P. (EVP, CFO), who traded 257.1K shares valued at $17.69M on Nov 16, 2026.

Live Market News & Developments
Aggregated real-time headlines for RPRX (RPRX)
6 updates

Royalty Pharma plc (RPRX) stock price, news, quote and history

Yahoo Finance UK7h ago

RPRX - Royalty Pharma plc Stock Price and Quote

Finviz177d ago

Royalty Pharma (RPRX) Stock Looks Richly Priced After Its 136% Run

Yahoo Finance57d ago

Royalty Pharma PLC $RPRX Stock: Danske Bank A S Grows Position

MarketBeat3d ago

Royalty Pharma (RPRX) Stock Looks Above Fair Value Despite Royalty Portfolio Focus

Simply Wall St13d ago

symbol__ Stock Quote Price and Forecast

CNN975d ago

FAQs About RPRX Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for RPRX.

Based on SEC Form 4 disclosures, the Insider Confidence Score for RPRX is currently 25/100, which reflects a moderate distribution bias. This calculation accounts for a total of 0 purchases and 3 sales by company executives over the last 90 days.

The CEO Conviction Index for RPRX is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.